Evaluation of CD56 and CD117 Double-Positivity as a Predictor of Poor Prognosis in Multiple Myeloma Patients: A Retrospective Analysis

Evaluation of CD56 and CD117 Double-Positivity as a Predictor of Poor Prognosis in Multiple Myeloma Patients: A Retrospective Analysis

Objective: Despite advancements in treatment, multiple myeloma (MM) remains a challenging hematologic malignancy. It is crucial to stratify risk and perform prognostic assessment with various markers, including the expression of cluster of differentiation 56 (CD56) and cluster of differentiation 117...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hakan Keski, Selim Merdan, Itır Ebru Zemheri
Format:	Article
Language:	English
Published:	Galenos Publishing House 2024-12-01
Series:	Turkish Journal of Hematology
Subjects:	multiple myeloma cytogenetic abnormalities cd56 cd117 survival
Online Access:	https://tjh.com.tr/jvi.aspx?pdir=tjh&plng=eng&un=TJH-14306
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

CD56briCD38+ as a novel neutrophil-specific marker in chronic myeloid leukemia
by: Panpan Huang, et al.
Published: (2024-11-01)

CD117 expression on blast cells in acute myeloid leukemia
by: Goryainova N.V., et al.
Published: (2015-09-01)

CD117 expression on blast cells in acute myeloid leukemia.
by: N. V. Goryainova, et al.
Published: (2015-09-01)

Role of CD117 and mast cells in periodontal diseases: Histological and immunohistochemical study
by: Fatin L. Khaphi, et al.
Published: (2025-03-01)

Transcriptional signature of CD56bright NK cells predicts favourable prognosis in bladder cancer
by: Md Abdullah Al Kamran Khan, et al.
Published: (2025-01-01)

Alginate-gelatin hydrogel promotes the neurogenic differentiation potential of bone marrow CD117+ hematopoietic stem cells
by: Jinshan Peng
Published: (2024-06-01)

The impact of high-risk cytogenetic abnormalities in extramedullary multiple myeloma in the era of novel agents: insights from a multicenter study
by: Dong Liang, et al.
Published: (2024-12-01)

Exploring the CD3/CD56/TNF-α/Caspase3 pathway in pyrethroid-induced immune dysregulation: curcumin-loaded chitosan nanoparticle intervention
by: Nawal Alsubaie, et al.
Published: (2025-02-01)

IMMUNOHISTOCHEMICALLY EVALUATION OF CD20 EXPRESSION IN PATIENTS WITH MULTIPLE MYELOMA
by: Irfan Yavasoglu, et al.
Published: (2014-08-01)

Light-chain amyloidosis with concomitant symptomatic myeloma (CRAB-SLiM features): clinical characteristics, cytogenetic abnormalities, and outcomes
by: Chenqi Yu, et al.
Published: (2024-11-01)

CD56neg CD16+ cells represent a distinct mature NK cell subset with altered phenotype and are associated with adverse clinical outcome upon expansion in AML
by: Julia Wlosik, et al.
Published: (2025-01-01)

Prognostic significance of perioperative circulating CD56bright NK cell and recovery of NK cell activity in patients with colorectal cancer undergoing radical surgery
by: Jeng-Fu You, et al.
Published: (2025-02-01)

ADA/CD26 axis increases intra-tumor PD-1+CD28+CD8+ T-cell fitness and affects NSCLC prognosis and response to ICB
by: Ornella Franzese, et al.
Published: (2024-12-01)

Injectable decellularized Wharton's jelly hydrogel containing CD56+ umbilical cord mesenchymal stem cell-derived exosomes for meniscus tear healing and cartilage protection
by: Simiao Kang, et al.
Published: (2024-12-01)

Monoclonal anti-CD38 therapy in human myeloma: retrospects and prospects
by: Alberto L. Horenstein, et al.
Published: (2025-02-01)

Dengue infection changes the expressions of CD154 and CD148 in human platelets
by: Sayali Vedpathak, et al.
Published: (2025-01-01)

INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
by: Duni Sawadogo, et al.
Published: (2013-04-01)

CD164 promotes tumor progression and predicts the poor prognosis of bladder cancer
by: Xiao‐Guang Zhang, et al.
Published: (2018-08-01)

Association of CD24, CD27, and co-stimulatory molecules CD80 immunological marker expression on B-cells of human peripheral blood with development of celiac disease
by: Rahab Abd-Ali Al-Madany, et al.
Published: (2024-12-01)

Antigen-Independent Maturation of CD2, CD11a/CD18,CD44, and CD58 Expression on Thymic Emigrants inFetal and Postnatal Sheep
by: Deborah A. Witherden, et al.
Published: (1995-01-01)

CD3-CD8 immune score associated with a clinical score stratifies PDAC prognosis regardless of adjuvant or neoadjuvant chemotherapy
by: Coralie Schoumacher, et al.
Published: (2024-12-01)

Shedding of membrane complement inhibitors CD59 and CD46 into the circulation is associated with poor prognosis in acute coronary syndrome patients: a cohort study
by: Baojun Zhong, et al.
Published: (2024-11-01)

Ligands of CD6: roles in the pathogenesis and treatment of cancer
by: Mikel Gurrea-Rubio, et al.
Published: (2025-01-01)

Co-stimulation of CD28/CD40 signaling molecule potentiates CAR-T cell efficacy and stemness
by: Wannakorn Khopanlert, et al.
Published: (2024-09-01)

CD38 regulates chronic lymphocytic leukemia proliferation via CD45 phosphatase activity
by: John F. Imbery, et al.
Published: (2024-09-01)

CD4+CD25+调节性T细胞的体外扩增
Published: (2008-01-01)

Gastrointestinal stromal tumor of large size, extragastrointestinal localization and different morphological features
by: Shpon’ka I.S., et al.
Published: (2015-09-01)

Gastrointestinal stromal tumor of large size, extragastrointestinal localization and different morphological features.
by: I. S. Shpon’ka, et al.
Published: (2015-09-01)

The Prognostic Significance of CD47, CD68, and CD163 Expression Levels and Their Relationship with MLR and MAR in Locally Advanced and Oligometastatic Nasopharyngeal Carcinoma
by: Asim Armagan Aydin, et al.
Published: (2024-11-01)

CD69+CD103+CD8+ tissue-resident memory T cells possess stronger anti-tumor activity and predict better prognosis in colorectal cancer
by: Zi-Xin Wu, et al.
Published: (2024-12-01)

Systematic exploration of the molecular characteristics of CD8+ T cells to predict the response to immunotherapy and the prognosis of patients with colon adenocarcinoma
by: Xin Shen, et al.
Published: (2024-12-01)

Lymphomatoid Papulosis Type E With T-Cell Receptor Gamma Positivity
by: Namasondhi A, et al.
Published: (2025-01-01)

CD155 promotes the progression of colorectal cancer by restraining CD8+ T cells via the PI3K/AKT/NF-κB pathway
by: Rongpu Liang, et al.
Published: (2025-02-01)

CD14loCD301b+ macrophages gathering as a proangiogenic marker in adipose tissues
by: Yibing Lv, et al.
Published: (2025-01-01)

Upregulation of CD244 promotes CD8+ T cell exhaustion in patients with alveolar echinococcosis and a murine model
by: Maolin Wang, et al.
Published: (2024-11-01)

MULTIPARAMETRIC FLOW CYTOMETRY REFINES RISK STRATIFICATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS
by: Francesca Fazio, et al.
Published: (2023-08-01)

Loop33 × 123 CAR-T targeting CD33 and CD123 against immune escape in acute myeloid leukemia
by: Haotian Ma, et al.
Published: (2024-11-01)

Combined prognostic value of the cancer stem cell markers CD47 and CD133 in esophageal squamous cell carcinoma
by: Jian‐Hua Wang, et al.
Published: (2019-03-01)

The novel CD16A/anti-CD3 bifunctional protein, eCD16A/anti-CD3-BFP, redirects T cell cytotoxicity toward antibody-bound target cells
by: Chien-Ting Lin, et al.
Published: (2025-12-01)

COVID-19 Vaccination and Transient Increase in CD4/CD8 Cell Counts in People with HIV: Evidence from China
by: Yanyan Li, et al.
Published: (2024-12-01)